Dr. Magoola unveils gene therapy breakthrough to transform sickle cell treatment
Dr. Magoola, who is leading Dei BioPharma to develop a manufacturing facility with atleast 26 different units, says the biotech ...
Tag: biotechnology
Dr. Magoola gets FDA boost for rare borne drug in US market
Dr. Matthias Magoola and Dei Biopharma have received a significant boost after the U.S. FDA accepted their application for a ...
Dei BioPharma’s Dr. Magoola unveils new mRNA Ebola and Mpox vaccines at Africa CDC meeting in South Africa
Ugandan firm Dei BioPharma, led by Dr. Matthias Magoola, secures new patent rights for innovative mRNA Ebola and Mpox vaccines. ...
Dei BioPharma receives second US FDA approval for key diabetes drug
Dei BioPharma projects $15B in annual revenue after its development plan for two novel GLP-1 drugs, liraglutide and semaglutide, is ...
TOP STORY: Dei BioPharma’s Dr. Magoola files new US patents for groundbreaking cancer and immune therapies
Dr. Magoola, Dei BioPharma, secures US patents for universal mRNA cancer vaccine & affordable scFv immune therapy. Global treatment equity, ...
BIG STORY! Dei Biophama to produce affordable, newly approved HIV drug in Uganda
The Dei BioPharma drugs and vaccines manufacturing facility in Matugga, near Kampala-Uganda. KAMPALA, Uganda — Ugandan biotechnology firm has announced it ...
Museveni applauds Dei Biopharma Founder Dr. Magoola over US patent for cancer treatment
President Museveni meets with Dr. Matthias Magoola, CEO of Dei Biopharma Ltd, and team to discuss their innovative projects, including ...
Ugandan scientist secures US patent for ground-breaking cancer treatment
Dr. Matthias Magoola, the founder and Chief Executive Officer of Dei Group of Companies, acknowledged and thanked the assistance of ...
UG Standard, published via www.ugstandard.com isa publication of Sahel Media Solutions Ltd, a professional Digital/New Media company in Uganda info@ugstandard.com